期刊文献+
共找到1,338篇文章
< 1 2 67 >
每页显示 20 50 100
Runx2 regulates peripheral nerve regeneration to promote Schwann cell migration and re-myelination 被引量:1
1
作者 Rong Hu Xinpeng Dun +1 位作者 Lolita Singh Matthew C.Banton 《Neural Regeneration Research》 SCIE CAS CSCD 2024年第7期1575-1583,共9页
Runx2 is a major regulator of osteoblast differentiation and function;however,the role of Runx2 in peripheral nerve repair is unclea r.Here,we analyzed Runx2expression following injury and found that it was specifical... Runx2 is a major regulator of osteoblast differentiation and function;however,the role of Runx2 in peripheral nerve repair is unclea r.Here,we analyzed Runx2expression following injury and found that it was specifically up-regulated in Schwann cells.Furthermore,using Schwann cell-specific Runx2 knocko ut mice,we studied peripheral nerve development and regeneration and found that multiple steps in the regeneration process following sciatic nerve injury were Runx2-dependent.Changes observed in Runx2 knoc kout mice include increased prolife ration of Schwann cells,impaired Schwann cell migration and axonal regrowth,reduced re-myelination of axo ns,and a block in macrophage clearance in the late stage of regeneration.Taken together,our findings indicate that Runx2 is a key regulator of Schwann cell plasticity,and therefore peripheral nerve repair.Thus,our study shows that Runx2 plays a major role in Schwann cell migration,re-myelination,and peripheral nerve functional recovery following injury. 展开更多
关键词 macrophage clearance MIGRATION peripheral nerve injury regeneration re-myelination RUNX2 Schwann cells
下载PDF
Evaluation of left ventricular systolic function in type 2 diabetes mellitus patients with and without peripheral vascular disease
2
作者 Guang-An Li Jun Huang Li Fan 《World Journal of Diabetes》 SCIE 2024年第6期1280-1290,共11页
BACKGROUND Peripheral vascular disease(PVD)is a common complication of type 2 diabetes mellitus(T2DM).Patients with T2DM have twice the risk of PVD as nondiabetic patients.AIM To evaluate left ventricular(LV)systolic ... BACKGROUND Peripheral vascular disease(PVD)is a common complication of type 2 diabetes mellitus(T2DM).Patients with T2DM have twice the risk of PVD as nondiabetic patients.AIM To evaluate left ventricular(LV)systolic function by layer-specific global longitudinal strain(GLS)and peak strain dispersion(PSD)in T2DM patients with and without PVD.METHODS Sixty-five T2DM patients without PVD,57 T2DM patients with PVD and 63 normal controls were enrolled in the study.Layer-specific GLS[GLS of the epimyocardium(GLSepi),GLS of the middle myocardium(GLSmid)and GLS of the endocardium(GLSendo)]and PSD were calculated.Receiver operating characteristic(ROC)analysis was performed to calculate the sensitivity and specificity of LV systolic dysfunction in T2DM patients with PVD.We calculated Pearson’s correlation coefficients between biochemical data,echocardiographic characteristics,and layer-specific GLS and PSD.RESULTS There were significant differences in GLSepi,GLSmid and GLSendo between normal controls,T2DM patients without PVD and T2DM patients with PVD(P<0.001).Trend tests revealed a ranking of normal controls>T2DM patients without PVD>T2DM patients with PVD in the absolute value of GLS(P<0.001).PSD differed significantly between the three groups,and the trend ranking was as follows:normal controls<T2DM patients without PVD<T2DM patients with PVD(P<0.001).ROC analysis revealed that the combination of layer-specific GLS and PSD had high diagnostic efficiency for detecting LV systolic dysfunction in T2DM patients with PVD.Lowdensity lipoprotein cholesterol was positively correlated with GLSepi,GLSmid and PSD(P<0.05),while LV ejection fraction was negatively correlated with GLSepi,GLSmid and GLSendo in T2DM patients with PVD(P<0.01).CONCLUSION PVD may aggravate the deterioration of LV systolic dysfunction in T2DM patients.Layer-specific GLS and PSD can be used to detect LV systolic dysfunction accurately and conveniently in T2DM patients with or without PVD. 展开更多
关键词 Type 2 diabetes mellitus peripheral vascular disease Speckle tracking echocardiography Global longitudinal strain Peak strain dispersion
下载PDF
2型糖尿病周围神经病变与胰岛β细胞功能的相关性研究
3
作者 蒋飞霞 黄炫赓 +5 位作者 黄济华 张薇 李郭乔 宁候发 余博先 苏宏业 《中国现代医生》 2024年第7期17-20,共4页
目的探讨2型糖尿病周围神经病变与胰岛β细胞功能的相关性。方法选取2020年1月至12月广西医科大学第二附属医院收治的298例2型糖尿病患者为研究对象,根据是否合并周围神经病变将其分为周围神经病变组(n=178)和无周围神经病变组(n=120)... 目的探讨2型糖尿病周围神经病变与胰岛β细胞功能的相关性。方法选取2020年1月至12月广西医科大学第二附属医院收治的298例2型糖尿病患者为研究对象,根据是否合并周围神经病变将其分为周围神经病变组(n=178)和无周围神经病变组(n=120)。采用二两馒头餐后30min净增C肽与葡萄糖比值(ΔC肽30/ΔG30)和30min净增胰岛素与葡萄糖比值(Δ胰岛素30/ΔG30)评估早期阶段胰岛分泌功能;采用二两馒头餐后120min血糖曲线下面积(area under the curve,AUC)校正后的C肽和胰岛素AUC(C肽_(AUC)/G_(AUC)、胰岛素_(AUC)/G_(AUC))评估总的β细胞分泌功能。多因素Logistic回归分析探讨2型糖尿病并发周围神经病变的危险因素。结果周围神经病变组患者的餐后60min C肽、120min C肽、ΔC肽30/ΔG30、C肽_(AUC)/G_(AUC)均显著低于无周围神经病变组(P<0.05)。ΔC肽30/ΔG30和C肽_(AUC)/G_(AUC)与高密度脂蛋白胆固醇、空腹血糖、餐后2h血糖、糖化血红蛋白均呈负相关,与体质量指数、尿酸均呈正相关(P<0.05)。多因素Logistic回归分析结果显示,空腹血糖升高、C肽_(AUC)/G_(AUC)降低均是糖尿病患者发生周围神经病变的独立危险因素(P<0.05)。结论2型糖尿病患者胰岛β细胞功能下降是糖尿病周围神经病变发病的独立危险因素,应积极保护胰岛β细胞功能以延缓周围神经病变的发生。 展开更多
关键词 2型糖尿病 Β细胞功能 周围神经病变
下载PDF
丹藤通脉方治疗2型糖尿病周围神经病变患者的临床疗效观察
4
作者 张萍 王智明 +2 位作者 隋淼 周传礼 李晨 《中医临床研究》 2024年第2期144-148,共5页
目的:探讨丹藤通脉方用于治疗2型糖尿病周围神经病变的临床疗效。方法:选择2019年1月-2021年12月在南京中医药大学附属徐州市中医院内分泌科住院治疗的2型糖尿病周围神经病变患者60例;采用随机法将上述患者分为观察组和对照组(每组30例)... 目的:探讨丹藤通脉方用于治疗2型糖尿病周围神经病变的临床疗效。方法:选择2019年1月-2021年12月在南京中医药大学附属徐州市中医院内分泌科住院治疗的2型糖尿病周围神经病变患者60例;采用随机法将上述患者分为观察组和对照组(每组30例);对照组给予基础治疗联合甲钴胺治疗,观察组在对照组治疗基础上给予联合丹藤通脉方治疗。治疗周期共12周,对比两组疗效。结果:治疗后组间效果比较,观察组患者的总有效率高于对照组(P<0.05)。多伦多临床评分系统(Troronto Clinical Scoring System,TCSS)评分低于对照组(P<0.05);空腹血糖(Glucose,GLU)、餐后2小时血糖(2-hour Postprandial Blood Glucose,2 h PG)、糖化血红蛋白(Hemoglobin A1c,HbA1c)水平低于对照组(P<0.05);总胆固醇(Total Cholesterol,TC)、三酰甘油(Triglycerides,TG)、低密度脂蛋白(Low Density Lipoprotein,LDL)水平低于对照组(P<0.05);右腓神经及正中神经的运动神经传导速度(Sensory Nerve Conduction Velocity,SNCV)和感觉神经传导速度(Motor Nerve Conduction Velocity,MNCV)高于对照组(P<0.05)。与治疗前比较,观察组和对照组治疗后的TCSS、GLU、2 h PG、HbA1c水平及TC、TG、LDL水平均降低(P<0.05),右腓神经及正中神经的MNCV和SNCV均升高(P<0.05)。结论:丹藤通脉方治疗糖尿病周围神经病变患者疗效确切,安全性良好,值得进一步推广。 展开更多
关键词 丹藤通脉方 2型糖尿病 糖尿病周围神经病变
下载PDF
青钱柳多糖调节胰岛和肝脏葡萄糖转运蛋白4转位干预2型糖尿病大鼠的作用机制
5
作者 刘海云 石淼婷 +5 位作者 骆欣怡 孙敏燕 徐晨曦 陈鲲翰 王晓敏 舒任庚 《医药导报》 CAS 北大核心 2024年第1期13-19,共7页
目的 观察青钱柳多糖调节胰岛和肝脏葡萄糖转运蛋白4(GLUT4)转位改善2型糖尿病(T2DM)大鼠外周胰岛抵抗的作用。方法 建立T2DM大鼠模型(给予高脂饲料后注射链脲佐菌素35 mg·kg^(-1)),将造模成功的大鼠随机分为模型对照组,青钱柳多... 目的 观察青钱柳多糖调节胰岛和肝脏葡萄糖转运蛋白4(GLUT4)转位改善2型糖尿病(T2DM)大鼠外周胰岛抵抗的作用。方法 建立T2DM大鼠模型(给予高脂饲料后注射链脲佐菌素35 mg·kg^(-1)),将造模成功的大鼠随机分为模型对照组,青钱柳多糖提取物小、大剂量组(5,10 g·kg^(-1))和盐酸二甲双胍组(0.25 g·kg^(-1)),每组9只,给药8周。测定空腹血糖、血脂变化;苏木精-伊红染色法观察胰岛和肝脏病理形态的改变;免疫组化法观察胰岛磷酸化磷酯酰肌醇3激酶(p-PI3K)、磷酸化丝氨酸苏氨酸蛋白激酶1(p-Akt1)、GLUT4蛋白的表达;免疫荧光观察肝脏和胰岛GLUT4转位。结果 与模型对照组比较,青钱柳多糖提取物小、大剂量组和盐酸二甲双胍组大鼠胰岛和肝脏结构较完整,血糖下降(P<0.05),高密度脂蛋白升高(P<0.05),胰岛p-PI3K、p-Akt1、GLUT4蛋白表达升高(P<0.05),肝脏和胰岛GLUT4转位增强(P<0.05)。结论 青钱柳多糖可调节T2DM大鼠糖脂紊乱,其机制可能是增强胰岛p-PI3K、p-Akt1、GLUT4蛋白的表达,促进肝脏和胰岛GLUT4转位,从而调节外周胰岛抵抗。 展开更多
关键词 青钱柳多糖 葡萄糖转运蛋白4转位 外周胰岛素抵抗 2型糖尿病
下载PDF
2型糖尿病合并DPN与糖尿病肾病、下肢动脉粥样硬化症的相关性
6
作者 蒋飞霞 黄炫赓 +5 位作者 黄济华 张薇 李郭乔 宁候发 余博先 苏宏业 《现代医药卫生》 2024年第2期181-184,共4页
目的探讨2型糖尿病合并糖尿病周围神经病变(DPN)与糖尿病肾病、下肢动脉粥样硬化症的相关性。方法选取2020年1-12月在该院内分泌科住院的T2DM患者298例,根据患者是否合并DPN分为DPN组(178例)和非DPN组(120例)。比较2组随机尿白蛋白/肌... 目的探讨2型糖尿病合并糖尿病周围神经病变(DPN)与糖尿病肾病、下肢动脉粥样硬化症的相关性。方法选取2020年1-12月在该院内分泌科住院的T2DM患者298例,根据患者是否合并DPN分为DPN组(178例)和非DPN组(120例)。比较2组随机尿白蛋白/肌酐比值(UACR)、空腹血糖(FBS)、餐后2 h C肽(2 h CP)水平及下肢动脉粥样硬化症、糖尿病肾病发生率等指标,同时分析DPN的独立危险因素。结果2组年龄、性别、病程及随机UACR、FBS、2 h CP水平比较,差异有统计学意义(P<0.05),而其余指标比较,差异无统计学意义(P>0.05)。2组下肢动脉粥样硬化症及糖尿病肾病发生率比较,差异有统计学意义(P<0.05)。下肢动脉粥样硬化症、糖尿病肾病是DPN的独立危险因素(P<0.05)。结论DPN与糖尿病肾病、下肢动脉粥样硬化症显著相关。 展开更多
关键词 2型糖尿病 周围神经病变 下肢动脉病变 糖尿病肾病
下载PDF
甲钴胺穴位注射治疗2型糖尿病周围神经病变临床观察
7
作者 陈晨 谢勤 华东平 《山西中医》 2024年第2期30-31,共2页
目的:观察甲钴胺穴位注射治疗2型糖尿病周围神经病变的临床效果。方法:选取符合纳入标准的62例2型糖尿病性周围神经病变患者,随机分为两组各31例。两组均接受基础治疗,对照组予甲钴胺片口服治疗;治疗组予甲钴胺注射液0.5 mg注射双侧足... 目的:观察甲钴胺穴位注射治疗2型糖尿病周围神经病变的临床效果。方法:选取符合纳入标准的62例2型糖尿病性周围神经病变患者,随机分为两组各31例。两组均接受基础治疗,对照组予甲钴胺片口服治疗;治疗组予甲钴胺注射液0.5 mg注射双侧足三里、悬钟穴位。两组疗程均为30天。比较两组患者治疗前后中医证候积分、多伦多临床评分(TCSS)的变化。结果:治疗组总有效率为93.55%,高于对照组的67.74%(P<0.05)。治疗后,两组患者中医证候评分和多伦多临床评分(TCSS)均较治疗前降低(P<0.01),且治疗组均优于对照组(P<0.05)。结论:采用甲钴胺注射液穴位注射治疗2型糖尿病周围神经病变能够改善患者临床症状,临床疗效较好。 展开更多
关键词 2型糖尿病周围神经病变 甲钴胺 穴位注射
下载PDF
计时起立-行走测试对老年2型糖尿病周围神经病变病人跌倒预测与风险评估价值研究
8
作者 吴小彬 张秀琼 +1 位作者 张莹 程婵婵 《循证护理》 2024年第15期2762-2765,共4页
目的:分析计时起立-行走测试(TUGT)对老年2型糖尿病周围神经病变病人跌倒风险的评估价值。方法:回顾性分析2020年1月—2022年12月在我院内分泌科纳入治疗的2型糖尿病周围神经病变病人120例为研究对象,收集病人一般资料、TUGT测试结果,采... 目的:分析计时起立-行走测试(TUGT)对老年2型糖尿病周围神经病变病人跌倒风险的评估价值。方法:回顾性分析2020年1月—2022年12月在我院内分泌科纳入治疗的2型糖尿病周围神经病变病人120例为研究对象,收集病人一般资料、TUGT测试结果,采用SPSS 22.0、R Studio 1.4.1103进行联合数据分析,研究相关性和预测价值。结果:本研究纳入的120例病人均顺利完成TUGT测试,完成率为100%,数据收集率为100%。所有病人TUGT时间为(16.03±3.29)s。Spearman相关性分析结果显示,TUGT时间与跌倒史、性别之间呈正相关(P<0.05);TUGT时间与2型糖尿病病程、合并周围神经病变病程、年龄之间无明显相关关系。TUGT时间用于预测老年2型糖尿病周围神经病变病人跌倒风险的最佳临界值为14.19 s,受试者工作特征曲线(ROC)曲线下面积(AUC)值为0.773,敏感度为86.29%,特异度为67.16%。结论:跌倒史、性别是影响老年2型糖尿病周围神经病变病人TUGT时间的危险因素,同时,TUGT时间对老年2型糖尿病周围神经病变病人跌倒具有良好的预测价值。 展开更多
关键词 计时起立-行走测试 老年 2型糖尿病 周围神经病变 跌倒
下载PDF
维生素D_(2)治疗糖尿病周围神经病变的临床研究
9
作者 高瑞萍 闫晓海 张秀云 《四川生理科学杂志》 2024年第10期2336-2338,共3页
目的:探讨维生素D_(2)通过提高25-羟维生素D[25(OH)D]水平提高糖尿病周围神经病变(Diabetes peripheral neuropathy,DPN)的治疗效果和安全性。方法:选取2022.2至2023.3期间于本院就诊的2型糖尿病(Type 2 diabetes mellitus,T2DM)合并DP... 目的:探讨维生素D_(2)通过提高25-羟维生素D[25(OH)D]水平提高糖尿病周围神经病变(Diabetes peripheral neuropathy,DPN)的治疗效果和安全性。方法:选取2022.2至2023.3期间于本院就诊的2型糖尿病(Type 2 diabetes mellitus,T2DM)合并DPN患者92例作为研究对象。随机将患者分为对照组和观察组,每组各46例。对照组控制血糖并采用甲钴胺片、硫辛酸注射液治疗。观察组在对照组基础上给与维生素D_(2)肌肉注射治疗。分析比较两组的周围神经运动神经传导速度(Motor nerve conduction velocity,MCV)、感觉神经传导速度(Sensory nerve conduction velocity,SCV)、血清25(OH)D水平、神经病变程度[密歇根糖尿病神经病变量表(Michigan Diabetic Neuropathy Score,MDNS)评分]和不良反应。结果:治疗后,两组的血清25-OH VD_(2)和25-OH VD3水平均较治疗前提高,且观察组的25-OH VD_(2)和25-OH VD3水平均明显高于对照组(P<0.05)。治疗后,两组的正中神经MCV、SCV和腓总神经MCV、SCV水平均较治疗前提高,且观察组的正中神经MCV、SCV和腓总神经MCV、SCV水平均明显高于对照组(P<0.05)。治疗后,两组的MDNS评分均较治疗前下降,且观察组的MDNS评分明显低于对照组(P<0.05)。两组的不良反应发生率比较无显著差异。结论:维生素D_(2)注射液治疗能提高T2DM合并DPN患者血清中25(OH)D水平,提高周围神经传导速度,改善患者临床症状且安全性高。 展开更多
关键词 维生素D_(2)注射液 糖尿病周围神经病变 25羟维生素D
下载PDF
α-硫辛酸联合依帕司他对2型糖尿病伴糖尿病周围神经病变患者肌电图、血清炎症因子及血流变学的影响
10
作者 覃君德 张琰 +2 位作者 蒙莲 黎达香 莫振华 《大医生》 2024年第13期32-35,共4页
目的探讨α-硫辛酸联合依帕司他治疗2型糖尿病(T2DM)伴糖尿病周围神经病变(DPN)患者的效果,并分析其对肌电图、血清炎症因子和血流变学指标的影响。方法按照随机数字表法将2021年9月至2023年9月广西科技大学第一附属医院收治的84例T2DM... 目的探讨α-硫辛酸联合依帕司他治疗2型糖尿病(T2DM)伴糖尿病周围神经病变(DPN)患者的效果,并分析其对肌电图、血清炎症因子和血流变学指标的影响。方法按照随机数字表法将2021年9月至2023年9月广西科技大学第一附属医院收治的84例T2DM合并DPN患者分为对照组(给予依帕司他治疗)和观察组(给予α-硫辛酸联合依帕司他治疗),各42例。比较两组患者肌电图指标、炎症因子和血流变学指标。结果治疗后,两组患者正中和腓总神经的运动神经传导速度(MCV)和感觉神经传导速度(SCV)水平均升高,且观察组均高于对照组(均P<0.05)。治疗后,两组患者超敏C反应蛋白(hs-CRP)和白细胞介素-6(IL-6)水平均较治疗前降低,且观察组均低于对照组(P<0.05)。治疗后,两组患者全血高切黏度、全血低切黏度和血浆黏度均低于治疗前,且观察组均低于对照组(均P<0.05)。结论给予T2DM合并DPN患者α-硫辛酸联合依帕司他治疗的效果显著,可有效提高神经传导速度,抑制炎症反应,调节血流变学。 展开更多
关键词 Α-硫辛酸 依帕司他 2型糖尿病 糖尿病周围神经病变 肌电图 炎症因子 血流变学
下载PDF
基于TXNIP/NLRP3炎性小体通路研究芪归通络颗粒对2型糖尿病大鼠坐骨神经的保护作用 被引量:1
11
作者 李金菊 阮诺冰 +2 位作者 杨浩 林逸轩 方朝晖 《陕西中医》 CAS 2024年第6期733-739,共7页
目的:基于硫氧还蛋白相互作用蛋白(TXNIP)/核苷酸结合寡聚化结构域样受体蛋白(NLRP)3炎性小体通路研究芪归通络颗粒对2型糖尿病大鼠坐骨神经的保护作用及潜在机制。方法:90只雄性SD大鼠随机选取10只为空白组,其余大鼠采取高脂饲料喂养联... 目的:基于硫氧还蛋白相互作用蛋白(TXNIP)/核苷酸结合寡聚化结构域样受体蛋白(NLRP)3炎性小体通路研究芪归通络颗粒对2型糖尿病大鼠坐骨神经的保护作用及潜在机制。方法:90只雄性SD大鼠随机选取10只为空白组,其余大鼠采取高脂饲料喂养联合STZ腹腔注射方法构建2型糖尿病周围神经病变大鼠模型,将造模成功大鼠随机分为模型组、硫辛酸组(60 mg/kg)、芪归通络颗粒高、中、低剂量组,剂量分别为9、4.5、2.25 g/(kg·d)。各给药组给予相应剂量药物灌胃,持续12周。实验过程中观察大鼠一般状态及血糖水平;处死前检测大鼠机械痛阈值(PWMT)和坐骨神经运动传导速度(MNCV);通过酶联免疫吸附试验(ELISA)检测血清炎症因子白介素(IL)-1β、IL-18、IL-6、肿瘤坏死因子-α(TNF-α)、环氧合酶-2(COX-2)、诱导型一氧化氮合酶(iNOS)水平,苏木素-伊红(HE)染色观察坐骨神经形态,Western blot检测坐骨神经组织TXNIP/NLRP3通路相关蛋白表达水平。结果:与空白组相比,模型组大鼠血糖、IL-1β、IL-18、IL-6、TNF-α、COX-2、iNOS明显升高(P<0.05),PWMT和MNCV明显下降(P<0.05),坐骨神经TXNIP、NLRP3、ASC、Caspase-1、IL-1β蛋白相对表达显著上调(P<0.05)。与模型组比较,用药治疗组的PWMT和MNCV明显增加(P<0.05),TXNIP、NLRP3、ASC、Caspase-1、IL-1β蛋白相对表达显著下调(P<0.05),血清IL-1β、IL-18、IL-6、TNF-α、COX-2、iNOS水平下降(P<0.05),坐骨神经病理形态明显改善。结论:芪归通络颗粒可增强2型糖尿病大鼠的坐骨神经功能,改善糖尿病周围神经病变,其潜在作用机制可能与抑制TXNIP/NLRP3炎性小体通路的激活有关。 展开更多
关键词 2型糖尿病 芪归通络颗粒 周围神经病变 硫氧还蛋白相互作用蛋白 炎症小体 白介素-1Β
下载PDF
Factors Associated with Peripheral Neuropathy in Type 2 Diabetes: Subclinical versus Confirmed Neuropathy 被引量:8
12
作者 Yogendranathsing Unmar Mohammad Ishraq Zafar 高峰 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2017年第3期337-342,共6页
This study determined the prevalence of diabetic peripheral neuropathy(DPN) and subclinical DPN(s DPN) in patients with type 2 diabetes mellitus(T2DM) using nerve conduction study(NCS) as a diagnostic tool. We also in... This study determined the prevalence of diabetic peripheral neuropathy(DPN) and subclinical DPN(s DPN) in patients with type 2 diabetes mellitus(T2DM) using nerve conduction study(NCS) as a diagnostic tool. We also investigated the factors associated with the development of s DPN and compared factors between the sD PN and confirmed DPN(cDPN). This cross-sectional study involved 240 T2DM patients who were successively admitted to the endocrinology wards of Wuhan Union Hospital over the period of January to December 2014. Data on the medical history, physical and laboratory examinations were collected. DPN was diagnosed using NCS. One-way ANOVA with least significant difference(LSD) analysis or chi-square tests was used to compare parameters among DNP-free, s DPN and c DPN patients. Independent factors associated with s DPN were determined using logistic regression. The results showed that 50.8% of the participants had DPN, and among them, 17.1% had sDPN. sDPN showed significant independent associations with age, height, HbA1c, presence of atherosclerosis and diabetic retinopathy. Patients with DPN differed significantly from those without DPN with respect to age, duration of disease(DOD), HbA1c, presence of atherosclerosis, diabetic retinopathy, nephropathy and hypertension. Patients with cDPN, relative to those with sDPN, had significantly longer DOD and higher prevalence of peripheral artery disease(PAD) and coronary artery disease(CAD). Our study suggests that a significant number of T2DM patients are affected by s DPN, and the development of this condition is associated with advanced age, tall stature, poor glycaemic control, presence of diabetic retinopathy and atherosclerosis. On the other hand, patients with cDPN tend to have a longer DOD and are more likely to suffer from PAD and CAD. 展开更多
关键词 diabetic peripheral neuropathy type 2 diabetes mellitus subclinical diabetic peripheral neuropathy nerve conduction study
下载PDF
Dynamic expression of Slit1–3 and Robo1–2 in the mouse peripheral nervous system after injury 被引量:6
13
作者 Bing Chen Lauren Carr Xin-Peng Dun 《Neural Regeneration Research》 SCIE CAS CSCD 2020年第5期948-958,共11页
The Slit family of axon guidance cues act as repulsive molecules for precise axon pathfinding and neuronal migration during nervous system development through interactions with specific Robo receptors.Although we prev... The Slit family of axon guidance cues act as repulsive molecules for precise axon pathfinding and neuronal migration during nervous system development through interactions with specific Robo receptors.Although we previously reported that Slit1–3 and their receptors Robo1 and Robo2 are highly expressed in the adult mouse peripheral nervous system,how this expression changes after injury has not been well studied.Herein,we constructed a peripheral nerve injury mouse model by transecting the right sciatic nerve.At 14 days after injury,quantitative real-time polymerase chain reaction was used to detect mRNA expression of Slit1–3 and Robo1–2 in L4–5 spinal cord and dorsal root ganglia,as well as the sciatic nerve.Immunohistochemical analysis was performed to examine Slit1–3,Robo1–2,neurofilament heavy chain,F4/80,and vimentin in L4–5 spinal cord,L4 dorsal root ganglia,and the sciatic nerve.Co-expression of Slit1–3 and Robo1–2 in L4 dorsal root ganglia was detected by in situ hybridization.In addition,Slit1–3 and Robo1–2 protein expression in L4–5 spinal cord,L4 dorsal root ganglia,and sciatic nerve were detected by western blot assay.The results showed no significant changes of Slit1–3 or Robo1–2 mRNA expression in the spinal cord within 14 days after injury.In the dorsal root ganglion,Slit1–3 and Robo1–2 mRNA expression were initially downregulated within 4 days after injury;however,Robo1–2 mRNA expression returned to the control level,while Slit1–3 mRNA expression remained upregulated during regeneration from 4–14 days after injury.In the sciatic nerve,Slit1–3 and their receptors Robo1–2 were all expressed in the proximal nerve stump;however,Slit1,Slit2,and Robo2 were barely detectable in the nerve bridge and distal nerve stump within 14 days after injury.Slit3 was highly ex-pressed in macrophages surrounding the nerve bridge and slightly downregulated in the distal nerve stump within 14 days after injury.Robo1 was upregulated in vimentin-positive cells and migrating Schwann cells inside the nerve bridge.Robo1 was also upregulated in Schwann cells of the distal nerve stump within 14 days after injury.Our findings indicate that Slit3 is the major ligand expressed in the nerve bridge and distal nerve stump during peripheral nerve regeneration,and Slit3/Robo signaling could play a key role in peripheral nerve repair after injury.This study was approved by Plymouth University Animal Welfare Ethical Review Board (approval No.30/3203) on April 12,2014. 展开更多
关键词 dorsal root GANGLION NERVE REGENERATION neural REGENERATION peripheral NERVE ROBO 1 ROBO 2 SCIATIC NERVE Slit1 Slit2 Slit3
下载PDF
玉泉胶囊联合依帕司他治疗2型糖尿病周围神经病变患者疗效与机制研究 被引量:1
14
作者 樊玉珠 梁贵廷 +2 位作者 王春亮 梁晶 段俊红 《中国药物应用与监测》 CAS 2024年第1期1-4,共4页
目的探讨玉泉胶囊联合依帕司他治疗2型糖尿病周围神经病变患者的疗效及对Keap1/Nrf2/ARE通路的影响。方法选取2021年6月—2023年1月石家庄市中医院收治的163例2型糖尿病周围神经病变患者,将其随机分为观察组(82例)和对照组(81例)。对照... 目的探讨玉泉胶囊联合依帕司他治疗2型糖尿病周围神经病变患者的疗效及对Keap1/Nrf2/ARE通路的影响。方法选取2021年6月—2023年1月石家庄市中医院收治的163例2型糖尿病周围神经病变患者,将其随机分为观察组(82例)和对照组(81例)。对照组患者给予依帕司他片,观察组患者在此基础上联合使用玉泉胶囊,两组均治疗6个月,比较两组患者的临床疗效、神经传导功能变化以及血清Keap1、Nrf2、ARE表达情况。结果观察组患者治疗总有效率显著高于对照组(P<0.05)。治疗后两组患者正中神经、腓总神经运动神经(感觉神经)传导速度以及振幅均较治疗前显著升高(P<0.05),而潜伏期较治疗前显著降低(P<0.05),治疗后观察组改善情况优于对照组(P<0.05)。治疗后两组患者Keap1蛋白相对表达量较治疗前显著降低(P<0.05),而NQO1、Nrf2以及ARE蛋白相对表达量均较治疗前显著升高(P<0.05),治疗后观察组改善情况优于对照组(P<0.05)。两组患者治疗期间均未发生药物相关不良反应。结论玉泉胶囊联合依帕司他治疗糖尿病周围神经病变可有效提高患者临床疗效,改善患者神经传导功能,其作用机制可能与调控Keap1/Nrf2/ARE信号传导通路有关。 展开更多
关键词 2型糖尿病 周围神经病变 玉泉胶囊 依帕司他 Keap1/Nrf2/ARE通路
下载PDF
Peripheral Neuropathy and Vasculopathy;Frequency and Associated Risk Factors in Newly Diagnosed Treatment Naive Type 2 Diabetes 被引量:5
15
作者 Iftikhar Haider Naqvi Abu Talib +3 位作者 Syed Tahseen Akhter Syeda Rida Abdi Saiyeda Nayema Zehra Rizvi Muhammad Ubaid 《Open Journal of Endocrine and Metabolic Diseases》 2018年第5期125-136,共12页
Background: The prevalence of diabetes in Pakistan is 11.45%. The reported prevalence of diabetic foot ulceration in Pakistan is between 4% and 10%, with the amputation rate of 8% - 21%. Peripheral neuropathy and vasc... Background: The prevalence of diabetes in Pakistan is 11.45%. The reported prevalence of diabetic foot ulceration in Pakistan is between 4% and 10%, with the amputation rate of 8% - 21%. Peripheral neuropathy and vasculopathy are main underlying cause of diabetic foot ulcers. Methodology: It was a cross-sectional non-interventional cohort study where all newly diagnosed treatment na&#239;ve type 2 diabetic patients were enrolled. Peripheral neuropathy and vasculopathy were detected by Michigan neuropathy screening instrument (MNSI) and ankle brachial index (ABI) respectively. Risk factors for peripheral neuropathy and vasculopathy were determined by univariate and multivariate logistic regression analysis. Statistical significance was considered with P value of Result: Fifty seven patients (37.7%) had early neuropathy with MNSI score of 3.3 ± 0.4. Thirty seven patients (20.6%) had vasculopathy with ABI score of 0.76 ± 0.11. Age (Odd ratio 1.07 (1.02 - 1.11), p 0.003), duration of symptoms (Odd ratio 1.11 95% CI: 1.05 - 1.17, p ≤ 0.001), high HbA1C % (Odd ratio 1.94 95% CI: 1.54 - 2.45, P ≤ 0.001), albumin creatinine ratio (Odd ratio 1.01, 95% CI: 1.00 - 1.01, P ≤ 0.001 ) and cholesterol level (Odd ratio 1.01 95% CI: 1.01 - 1.02, p = 0.001) were found as risk factors for early neuropathy and vasculopathy. Conclusion: Peripheral neuropathy and vasculopathy are frequently reported complications among newly diagnosed treatment na&#239;ve patients of type 2 DM. Age, duration of symptoms prior to diagnosis, metabolic parameters like raised HbA1C, hyperlipidemia and spot random albumin creatinine ratio are found to be risk factors for both peripheral neuropathy and vasculopathy. 展开更多
关键词 peripheral NEUROPATHY peripheral VASCULOPATHY Type 2 Diabetes MELLITUS
下载PDF
HLA class Ⅱ alleles and risk for peripheral neuropathy in type 2 diabetes patients 被引量:2
16
作者 Ahmad Marzban Javad Kiani +3 位作者 Mehrdad Hajilooi Hamzeh Rezaei Zohreh Kahramfar Ghasem Solgi 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第11期1839-1844,共6页
The potential impact of human leukocyte antigen (HLA) genotype variations on development of diabetic peripheral neuropathy (DPN) is not well determined. This study aimed to identify the association of HLA class II... The potential impact of human leukocyte antigen (HLA) genotype variations on development of diabetic peripheral neuropathy (DPN) is not well determined. This study aimed to identify the association of HLA class II alleles with DPN in type 2 diabetes (T2D) patients. Totally 106 T2D patients, 49 with DPN and 57 without DPN, and 100 ethnic-matched healthy controls were analyzed. Both groups of the patients were matched based on sex, age, body mass index (BMI) and duration of T2D. Polyneuropathy was diagnosed using electrodiagnostic methods. HLA-DRB1 and DQB1 genotyping was performed in all subjects by the polymerase chain reaction with sequence-specific primers (PCR-SSP) method. T2D patients with DPN showed higher frequencies of HLA-DRB1*10 and DRB1*12 alleles compared to control group (P = 0.04). HLA-DQB1*02 allele and HLA-DRB1*07-DQB1*02 haplotype were associated with a decreased risk for developing DPN in T2D patients (P = 0.02 and P = 0.05 respectively). Also, patients with severe neuropathy showed higher frequencies of DRB1*07 (P = 0.003) and DQB1*02 (P = 0.02) alleles than those with mild-to-moderate form of neuropathy. The distribution of DRB 1 and DQB 1 alleles and haplotypes were not statistically different between all patients and healthy controls. Our findings implicate a possible protective role of HLA-DQB1*02 allele and HLA-DRB1*07-DQB1*02 haplotype against development of peripheral neuropathy in T2D patients. Therefore, variations in HLA genotypes might be used as genetic markers for prediction and potentially management of neuropathy in T2D patients. 展开更多
关键词 nerve regeneration HLA-DRB1 HLA-DQB1 alleles GENOTYPES haplotypes peripheral neuropathy type 2 diabetes neural regeneration
下载PDF
Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link? 被引量:2
17
作者 Pedro Valdivielso José Ramírez-Bollero Carmen Pérez-López 《World Journal of Diabetes》 SCIE CAS 2014年第5期577-585,共9页
Peripheral arterial disease, manifested as intermittent claudication or critical ischaemia, or identified by an ankle/brachial index < 0.9, is present in at least one in every four patients with type 2 diabetes mel... Peripheral arterial disease, manifested as intermittent claudication or critical ischaemia, or identified by an ankle/brachial index < 0.9, is present in at least one in every four patients with type 2 diabetes mellitus.Several reasons exist for peripheral arterial disease indiabetes. In addition to hyperglycaemia, smoking and hypertension, the dyslipidaemia that accompanies type2 diabetes and is characterised by increased triglyceride levels and reduced high-density lipoprotein cholesterol concentrations also seems to contribute to this association. Recent years have witnessed an increased interest in postprandial lipidaemia, as a result of various prospective studies showing that non-fasting triglycerides predict the onset of arteriosclerotic cardiovascular disease better than fasting measurements do. Additionally,the use of certain specific postprandial particle markers,such as apolipoprotein B-48, makes it easier and more simple to approach the postprandial phenomenon. Despite this, only a few studies have evaluated the role of postprandial triglycerides in the development of peripheral arterial disease and type 2 diabetes. The purpose of this review is to examine the epidemiology and risk factors of peripheral arterial disease in type 2 diabetes, focusing on the role of postprandial triglycerides and particles. 展开更多
关键词 peripheral ARTERIAL disease Type 2 diabetes POSTPRANDIAL lipidaemia APOLIPOPROTEIN B-48 Anklebrachial index Non-fasting TRIGLYCERIDES
下载PDF
磁共振扩散张量成像技术在2型糖尿病并发症中的应用进展 被引量:1
18
作者 胡婧 王玉洁 +1 位作者 张嵩浩 王丽芹 《中国医药导报》 CAS 2024年第10期196-198,共3页
2型糖尿病(T2DM)是以血糖异常为主要特征的慢性代谢性疾病,发病率高,病程长,严重影响患者生活质量。长期血糖增高,容易使大血管、微血管受损,造成眼、肾、神经、心脏、血管等多种组织器官功能障碍甚至衰竭,出现严重并发症。T2DM并发症... 2型糖尿病(T2DM)是以血糖异常为主要特征的慢性代谢性疾病,发病率高,病程长,严重影响患者生活质量。长期血糖增高,容易使大血管、微血管受损,造成眼、肾、神经、心脏、血管等多种组织器官功能障碍甚至衰竭,出现严重并发症。T2DM并发症对人类健康危害极大,是多数患者死亡或者残疾的主要原因。因此,早期诊断和鉴别对指导治疗至关重要。磁共振扩散张量成像技术(DTI)对于描绘组织微观结构具有独特优势,在糖尿病肾病、糖尿病周围神经病变及糖尿病视网膜病变等并发症中被广泛应用,已取得较好成果。本文就DTI技术在T2DM并发症中的应用进行综述,以期为临床诊治提供新思路。 展开更多
关键词 磁共振扩散张量成像 2型糖尿病 糖尿病周围神经病变 糖尿病肾病 糖尿病视网膜病变 认知障碍
下载PDF
基于COX-2/PGE2信号通路探讨温肾消癥汤减轻子宫内膜异位症小鼠疼痛的作用机制
19
作者 汪逸纯 万贵平 张真真 《浙江中医药大学学报》 CAS 2024年第10期1199-1208,1223,共11页
[目的]基于环氧合酶-2/前列腺素E2(cyclooxyfenase-2/prostaglandin E2,COX-2/PGE2)信号通路,探讨温肾消癥汤对子宫内膜异位症(endometriosis,EMS)模型小鼠疼痛的影响及其作用机制。[方法]采用腹腔注射法建立EMS小鼠模型40只作为造模组... [目的]基于环氧合酶-2/前列腺素E2(cyclooxyfenase-2/prostaglandin E2,COX-2/PGE2)信号通路,探讨温肾消癥汤对子宫内膜异位症(endometriosis,EMS)模型小鼠疼痛的影响及其作用机制。[方法]采用腹腔注射法建立EMS小鼠模型40只作为造模组,并随机将造模组分为EMS模型组(0.2 mL无菌蒸馏水)、温肾消癥汤组(0.2 mL温肾消癥汤浓缩液)、阳性对照组(0.2 mL阿司匹林混悬液),其他10只小鼠设为假手术组。造模21 d中,以Von Frey纤维丝实验与热板实验检测造模组与假手术组小鼠机械疼痛与热敏疼痛阈值。给药的21 d中,以Von Frey纤维丝实验与热板实验检测EMS模型组、温肾消癥汤组、阳性对照组小鼠机械疼痛与热敏疼痛阈值。给药21 d后,每天阴道涂片确定小鼠动情周期。在同一动情周期处死小鼠,并留取血清,腹腔冲洗液(peritoneal fluid,PF),内膜组织(在位、异位),丘脑,脊髓,背根神经节(dorsal root ganglion,DRG)。以酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)测定各样本中COX-2、PGE2、瞬时电位受体V1(transient receptor potential vanilloid 1,TRPV1)、钠电压门控通道α亚基11(sodium channel protein type 11 subunit alpha,SCN11A)含量。[结果]与假手术组比较,造模后小鼠足部与腹部痛阈均降低(P<0.05)。与EMS模型组比较,温肾消癥汤组小鼠给药后足部痛阈、腹部痛阈均提高(P<0.05)。与EMS模型组比较,温肾消癥汤组小鼠血清,在位内膜,PF,神经系统(丘脑、脊髓、DRG)中COX-2、PGE2,中枢神经系统(丘脑、脊髓)中TRPV1和外周神经系统(DRG)中SCN11A含量均降低(P<0.05)。与阳性对照组比较,温肾消癥汤组小鼠给药后血清、异位病灶、脊髓中PGE2含量均降低(P<0.05)。[结论]温肾消癥汤能够缓解子宫内膜异位症模型小鼠疼痛,其机制可能与抑制COX-2/PGE2信号通路的过度表达有关。 展开更多
关键词 子宫内膜异位症 疼痛 COX-2 PGE2 中枢敏化 外周敏化
下载PDF
2型糖尿病患者血清甲状腺激素及抗体表达水平与糖尿病周围神经病变的关系 被引量:2
20
作者 程志强 袁志娟 +1 位作者 吕磊 高会文 《川北医学院学报》 CAS 2024年第4期480-483,共4页
目的:探讨甲状腺激素、抗体在2型糖尿病中的表达及其与患者糖尿病周围神经病变的关系。方法:将2型糖尿病合并糖尿病周围神经病变的106例患者作为B组;将无合并糖尿病周围神经病变的118例患者作为A组。比较两组一般资料、甲状腺激素水平... 目的:探讨甲状腺激素、抗体在2型糖尿病中的表达及其与患者糖尿病周围神经病变的关系。方法:将2型糖尿病合并糖尿病周围神经病变的106例患者作为B组;将无合并糖尿病周围神经病变的118例患者作为A组。比较两组一般资料、甲状腺激素水平、抗体表达水平,用Logistic回归分析法分析2型糖尿病患者合并糖尿病周围神经病变的危险因素。结果:与A组相比,B组年龄较大,2型糖尿病病程更长(P<0.05);外周血抗甲状腺球蛋白抗体(TG-Ab)、抗甲状腺过氧化物酶抗体(TPO-Ab)、血清促甲状腺激素(TSH)、空腹胰岛素(FINS)水平、HOMA-IR指数更高(P<0.05);外周血TR-Ab水平更低(P<0.05)。Logistic回归分析结果显示,影响2型糖尿病患者合并糖尿病周围神经病变的危险因素为2型糖尿病病程较长、HOMA-IR指数、外周血TPO-Ab、血清FINS、TSH水平较高(OR=1.468、1.372、1.338、1.435、1.344),差异均具有统计学意义(P<0.05)。结论:2型糖尿病病程长、血糖情况、血清甲状腺激素及抗体表达水平异常的2型糖尿病患者,其合并糖尿病周围神经病变的几率更高,对于2型糖尿病合并糖尿病周围神经病变的患者,其甲状腺功能状况在评价其病情和预后方面有重要意义。 展开更多
关键词 2型糖尿病 甲状腺激素 抗体 周围神经病变 关系
下载PDF
上一页 1 2 67 下一页 到第
使用帮助 返回顶部